NEW YORK (GenomeWeb News) – Knome has raised almost $5.8 million toward a targeted goal of $6.3 million, the bioinformatics firm said recently in a regulatory document.

The company did not respond to a request for comment. It did not say in its Form D filed with the US Securities and Exchange Commission who the investors are or how the funds would be used.

The securities offered were in the form of debt.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."